Peanut Allergy: An Overview

被引:30
|
作者
Nasser Al-Ahmed
Shirina Alsowaidi
Peter Vadas
机构
[1] University of Toronto,Division of Allergy and Clinical Immunology, St. Michael's Hospital
[2] St. Michael's Hospital,Division of Allergy and Clinical Immunology, Carter Wing, Room 8
关键词
peanut; allergy; anaphylaxis; nuts;
D O I
10.1186/1710-1492-4-4-139
中图分类号
学科分类号
摘要
Peanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy range from mild to severe, and risk factors predisposing to severe reactions are discussed. However, even in the absence of risk factors, peanut allergic individuals may still experience life-threatening anaphylactic reactions. Approaches to investigation and treatment, patterns of cross-reactivity and possible causes of rising prevalence are discussed.
引用
收藏
相关论文
共 50 条
  • [31] Household peanut consumption as a risk factor for the development of peanut allergy
    Fox, Adam T.
    Sasieni, Peter
    du Toit, George
    Syed, Huma
    Lack, Gideon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 417 - 423
  • [32] Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: A randomized controlled study
    Dua, Shelley
    Ruiz-Garcia, Monica
    Bond, Simon
    Durham, Stephen R.
    Kimber, Ian
    Mills, Clare
    Roberts, Graham
    Skypala, Isabel
    Wason, James
    Ewan, Pamela
    Boyle, Robert
    Clark, Andrew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (06) : 1584 - +
  • [33] Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom
    Scott, Laura A.
    Berni, Thomas R.
    Berni, Ellen R.
    De Vries, Jane
    Currie, Craig J.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (08) : 889 - 896
  • [34] Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy
    Srivastava, Kamal D.
    Siefert, Alyssa
    Fahmy, Tarek M.
    Caplan, Michael J.
    Li, Xiu-Min
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (02) : 536 - +
  • [35] BSACI guideline for the diagnosis and management of peanut and tree nut allergy
    Stiefel, G.
    Anagnostou, K.
    Boyle, R. J.
    Brathwaite, N.
    Ewan, P.
    Fox, A. T.
    Huber, P.
    Luyt, D.
    Till, S. J.
    Venter, C.
    Clark, A. T.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (06): : 719 - 739
  • [36] Targeting Pim1 kinase in the treatment of peanut allergy
    Wang, Meiqin
    Gelfand, Erwin W.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (02) : 177 - 183
  • [37] Genetics of peanut allergy: A twin study
    Sicherer, SH
    Furlong, TJ
    Maes, HH
    Desnick, RJ
    Sampson, HA
    Gelb, BD
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (01) : 53 - 56
  • [38] New Medications in the Treatment of Peanut Allergy
    Walker, Scot
    HOSPITAL PHARMACY, 2018, 53 (06) : 369 - 370
  • [39] Current and Future Treatment of Peanut Allergy
    Vickery, Brian P.
    Ebisawa, Motohiro
    Shreffler, Wayne G.
    Wood, Robert A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02): : 357 - 365
  • [40] Current Trend in Immunotherapy for Peanut Allergy
    Chan, Chong Joo
    Richardo, Timmy
    Lim, Renee Lay Hong
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2018, 37 (06) : 279 - 290